Summary
Obesity, one of the main causes of metabolic syndrome (MetS), is an increasingly common health and economic problem worldwide, and one of the major risk factors for developing type 2 diabetes and cardiovascular disease. Chronic, low-grade inflammation is associated with MetS and obesity. A dominant type 2/anti-inflammatory response is required for metabolic homoeostasis within adipose tissue: during obesity, this response is replaced by infiltrating, inflammatory macrophages and T cells.
Helminths and certain protozoan parasites are able to manipulate the host immune response towards a TH2 immune phenotype that is beneficial for their survival, and there is emerging data that there is an inverse correlation between the incidence of MetS and helminth infections, suggesting that, as with autoimmune and allergic diseases, helminths may play a protective role against MetS disease. Within this review, we will focus primarily on the excretory-secretory products that the parasites produce to modulate the immune system and discuss their potential use as therapeutics against MetS and its associated pathologies.
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| INTRODUCTION
Metabolic syndrome (MetS), which presents as a cluster of conditions such as hypertension, abdominal obesity, high fasting plasma glucose and dyslipidaemia, is associated with a greater risk of developing type 2 diabetes (T2D) and cardiovascular diseases (CVD) such as atherosclerosis, the leading causes of mortality worldwide. The underlying mechanisms of MetS are still not fully understood, but it is notable that the majority of patients with the syndrome exhibit some degree of insulin resistance (IR). There are many factors that contribute to the development of IR, including obesity, physical inactivity, age, diet and genetic factors, with obesity and physical inactivity being the main driving force in most cases. Thus, the mechanisms by which obesity may contribute to metabolic dysfunction have been under intense investigation in recent years. Hotamisligil et al. 1 were the first to observe a significant increase in the levels of the pro-inflammatory cytokine TNF-α in obese mice, thereby linking inflammatory responses to obesity. Chronic inflammation has since been found to be strongly associated with obesity and MetS-obese people with MetS have an increased level of circulating inflammatory markers such as C-reactive protein, 2 and there is an increased incidence of cardiovascular diseases in patients with inflammatory diseases such as rheumatoid arthritis (RA). 3 Under normal physiological circumstances, excess nutrients are processed and stored by professional metabolic tissues-the liver, white adipose tissue (WAT) and skeletal muscle. In obese individuals, these tissues can become overloaded, resulting in an increase in free fatty acids in the tissues and circulation, leading to cellular metabolic dysregulation manifesting as mitochondrial dysfunction, oxidative stress and an increase in intracellular lipids. Obesity-induced cellular dysfunction results in the activation of a number of intracellular signalling pathways such as those involving mammalian target of rapamycin (mTOR), c-Jun amino-terminal kinase (JNK) and inhibitor of kappa kinase (IKKβ). In turn, these pathways converge and inhibit insulin signalling, primarily via serine phosphorylation of insulin receptor *These authors contributed jointly to this study.
substrate (IRS) proteins, blunting insulin action in these tissues and leading to IR. 
| INTRACELLULAR SIGNALLING PATHWAYS INVOLVED IN OBESITY AND METS
The signalling cascade of PI3K/AKT/mTOR has a profound influence on cell survival, 5 regulation of insulin sensitivity/resistance and cell metabolism. 6 Specifically, the recently demonstrated ability of the mTOR inhibitor, rapamycin, to prevent insulin resistance in humans 7 has highlighted this pathway as a point of intervention for MetS. The PI3K/AKT signalling cascade is activated by ligation of a range of receptors including G protein-coupled receptors, B-and T-cell receptors and tyrosine kinase receptors such as the insulin and insulin-like growth factor 1 (IGF-1) receptor (Figure 1 ). 8 The last two receptors stimulate IRS-1 and IRS-2 to activate PI3K, which in turn results in the phosphorylation and activation of AKT. 9, 10 In addition, the activation of the IIS (insulin/insulin-like growth signalling) pathway leads to the upregulation of mTOR complex 2 (mTORC2) and PDK1 activity, which are both required for the complete phosphorylation of AKT.
11
To date, AKT has been demonstrated to have multiple roles: regulating mTORC1 activation, mediating cell survival via the suppression of apoptosis-associated proteins such as Bad, 12 inhibiting Fox0 transcription 13 and regulating NF-κB activity.
14 Reflecting this, in the context of insulin signalling, the activation of AKT is essential for the upregulation of mTORC1 activity (via the inactivation of tuberous sclerosis complexes 1 and 2 (TSC1/2) and activation of S6 kinase (S6K)). Nonetheless, these findings strongly support the NLRP3 inflammasome as an attractive therapeutic target against obesity and MetS, and indeed, treatment with the IL-1 inhibitor Anakinra has been shown to improve pancreatic β-cell secretory functions and reduce systemic inflammatory markers C-reactive protein (CRP) and IL-6 in T2D patients. 34 Together, these studies demonstrate that there are multiple signalling pathways that are activated in times of nutrient excess that contribute to the inflammatory response in obesity and that targeting of these pathways can be beneficial when it comes to novel treatments for patients with MetS.
| CELLULAR COMPOSITION OF ADIPOSE TISSUE DURING OBESITY
Activation of these inflammatory pathways and consequent re- 
| PARASITES AND ASSOCIATED IMMUNE RESPONSES
Helminths, and the products they produce, are the most potent natural inducers of a type 2 immune response. 50 One of the key mechanisms utilized by helminths to induce this immune phenotype is the production of excretory-secretory (ES) products which interact with and influence their host's immune system. 51, 52 However, in the past fifty years, due to increased hygiene and advancement of medicine, we have drastically reduced the rate of infectious diseases such as those associated with helminths in the developed world. By contrast, during this time, the rate of allergic, autoimmune and inflammatory conditions such as asthma, rheumatoid arthritis and MetS-associated diseases has increased. In attempting to link these observations together, it is pertinent that helminth infections and their products can be utilized in murine model systems to treat allergic and autoimmune diseases, and currently, there are number of clinical trials in progress, or being planned, that utilize helminths in the treatment of a range of allergic and autoimmune diseases (reviewed by 53, 54 ).
Helminths are not alone in their ability to modulate the host immune response to create an optimum environment-protozoan para- Currently, there is a great deal of ongoing work examining the effect of helminth infection on metabolic syndrome: however, the present review will examine in detail the potential of parasite products, in particular, excretory-secretory products, to influence the immune system, and specifically their effect on the MetS.
| EXCRETORY-SECRETORY PRODUCTS OF PARASITES
Helminths are able to modulate the host immune response to ensure their own survival. One of the main mechanisms employed by these pathogens is the release of ES products that actively dampen the host immune response to the parasite. These products are a diverse mix of proteins, glycans, lipids and nucleic acids, and while they may utilize different mechanisms, in general, they induce a type 2/regulatory phenotype in the host (see Table 1 ). ES-62, a
The mechanisms of action of some of the best characterized parasite-derived excretory-secretory products on the immune system and in murine disease models are summarized Protozoan parasites also produce a range of secreted products that influence the host to ensure their own survival. One of the best studied molecules constitutes a group of cysteine proteases (CPs) produced by L. mexicana. 87 It has been demonstrated that this highly active group of cathepsin-L-like proteases is primarily produced by the amastigote (intracellular form of parasite), 88 and their role as a key virulence factor during infection has been confirmed in a number of studies through the use of a variety of CP mutant promastigotes. 55 Further evidence suggests that the most abundantly expressed form of L. mexicana-specific CP, CPB2.8, can drive a TH2 response in vivo. Pollock et al. 59 have demonstrated that administration of purified recombinant CPB2.8 can stimulate both IL-4
and IL-5 production in the draining lymph node and can enhance circulating IgE titres. The mechanisms underpinning these findings remain unclear; however, it should be considered that the CPs are similar in structure to other allergy-inducing proteases such as dust mite derived DerpI, a potent inducer of IL-4 and IgE. 89 Thus, it is perhaps unsurprising that CPB2.8 is so effective in polarizing the immune response from a TH1-dominated healing response to a TH2-dominated chronic phenotype. Hence, these Leishmania secreted CPs represent a group of potentially novel immunomodulatory molecules.
| HELMINTH ES AND METS
The strong TH2 response generated in response to SEA and LNFPIII led Bhargava et al. 85 to investigate whether these products have any effect on chronic inflammation with respect to obesity and hence can subsequently improve metabolic function in HFD-fed mice. Injection of either for 4 or 6 weeks after the onset of obesity in HFD mice augmented the production of IL-10, as well as increasing insulin sensitivity. Unlike with live helminth infection, 65 neither treatment had any effect on body weight or circulating lipid or adiponectin concentrations. 85 However, both LNFPIII and SEA had significant effects on the cell composition/interactions in the WAT-there was a decrease in the number of observed crown-like structures (CLS), and the expression of inflammatory genes such as TNF-α, Casp1, nlrp3, il18 and il1β
was reduced with a corresponding increase in il10 and the M2 genes Arg1 and MgL1. 85 It has recently been demonstrated that SEA mediates this improvement in metabolic homoeostasis by restoring the type 2 response in the WAT through the induction of eosinophil recruitment, 65 which has previously been shown to be crucial in promoting the accumulation of M2 macrophages. These changes are not due to direct effects of LNFPIII on adipocytes:
they appear to be mediated indirectly via production of IL-10 by macrophages as conditioned medium from LNFPIII-primed macrophages from WT but not IL-10 −/− mice improved insulin responsiveness in 3T3-l1 adipocytes. 85 SEA and LNFPIII were also demonstrated to have a strong protective effect on diet-induced hepatic steatosis, with treated HFD mice exhibiting reduced serum levels of the triglycerides, aspartate aminotransferase (AST) and liver aminotransferases (ALT) as well as decreases in genes associated with lipogenesis such as Srebp, in the liver. 85 Of interest, while not a secreted helminth product, L. sigmodontis antigen (LsAg) has also been demonstrated to mediate some protection against MetS, as therapeutic administration of LsAg for a two-week period improves glucose tolerance in diet-induced obese mice. This protection was found to require eosinophils but to be independent of CD4 + FOXP3 + T cells. 66 Treatment of the pre-adipocyte cell line (3T3-L1) with LsAg was found to inhibit their differentiation into mature adipocytes, suggesting LsAg may also be able to suppress adipogenesis. 66 It will therefore be interesting to see whether Ls ES products have similar properties.
| HELMINTH ES AND ATHEROSCLEROSIS
Atherosclerosis is a disease of the arteries, caused by lipid deposition and intimal thickening of the aorta and larger arteries, characterized by sustained inflammatory responses, specifically the chronic activation of macrophages. 90, 91 MetS significantly increases the risk of atherosclerosis, which is one of the main underlying pathologies for cardiovascular diseases such as stroke and myocardial infarctions, and as alluded to earlier, the leading cause of death in the Western world. ; however, there was no effect on lesion size or inflammation, a perhaps surprising observation which the authors speculated could be a result of using dead eggs and heat-treated SEA in this study. 
| CAN OTHER PARASITE MOLECULES INFLUENCE THE OUTCOME OF METS?
The seminal work carried out by Bhargava (2012) has shown that modulation of inflammatory responses by a parasite-derived product can significantly impact on the outcome of MetS in obese mice. prolonged phosphorylation of STAT3 and STAT6, resulting in the suppression of IL-12 production. 99, 100 Further to this, ROP16-mediated STAT6 activation has also been associated with enhanced levels of arginase-1 production in both macrophages and fibroblasts. Thus, the secreted ROP16 appears to be instrumental in ablating TH2-suppressive cytokine production and also promoting M2 macrophage polarization. 101 Moreover, ROPs do not appear to be the only protozoan products to exhibit this effect: for example, a T. gondii-specific peroxiredoxin (Prx) known as rTgPRx, 102 which has recently been shown to be a potent anti-inflammatory molecule, 103 appears to promote development of an AAM phenotype via STAT6-dependent and STAT6-independent enhancement of arginase-1 and YM1 expression.
In addition, the recombinant protein has been shown to stimulate the expression of IL-10 to further reinforce the regulatory/TH2-type response.
These marked effects of the protozoan Prx may not be so surprising and TNF-α and increased IL-10 production. As mentioned earlier in the review, MyD88 appears to be a crucial integrator of TLR and inflammasome signals impacting on obesity and MetS, 112 and one of the key mechanisms of ES-62 in its protection in CIA and lupus models is the degradation of this signalling adaptor. 95, 96 Interestingly, ES-62 has also been demonstrated to strongly suppress the basal levels of active AKT in DCs in vitro in a TLR4-dependent manner, 81 thus suggesting that it can target multiple layers of the pathways necessary to reduce the damaging pro-inflammatory immune response generated during MetS. 
| CONCLUSIONS

DISCLOSURES
None.
F I G U R E 2 Parasite excretory-secretory products are able to influence a range of signalling pathways such as PI3K/AKT and the inflammasome, as well as biasing immune system cells towards a type 2 phenotype, both of which suggest they may be able to provide protection against MetS
